INSIGHTS ON DRUG DEVELOPMENT

• Satisfying Aggressive Timelines With A Simplified Supply Chain For Drug Delivery

  To meet an aggressive timeline with a lack of resources, Kaleido Biosciences had to consider an alternative yet efficient route.

• Beyond HPLCs: Advanced Analytical Tools For The Development And Analysis Of Drug Products

  Advanced analytical techniques can provide timely insights into a product’s stability, performance, and composition. View this webinar to get expert insights on the applications of analytical techniques to help answer various questions during the product development process with an emphasis on Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).

• A Roadmap For Early Development To Commercial Manufacturing

  A key hurdle for any drug development program is bringing the drug to clinical studies. In this webcast, industry experts have presented  key topics to consider when planning for scale-up of a development program. Real-life examples to illustrate issues that have resulted in ineffective technology transfers—and strategies that can be employed to overcome these issues. Watch the webinar to learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach.

• The Next Generation ODT

  Orally dissolving tablets (ODT) are designed to dissolve rapidly on contact with saliva, therefore eliminating the need to chew the tablet, swallow the intact tablet, or take the tablet with liquids. Zydis® ODT fast-dissolve formulation from Catalent is a unique, freeze-dried tablet that disperses instantly in the mouth in less than three seconds. View the webinar to get an overview of the Zydis ODT technology, including new ways to administer peptides and vaccines. The webinar also presents the highlights of the next generation ODT technology, Zydis Ultra which can provide a better solution in terms of improved taste masking, innovative functional coating and a wide range of applications from Rx to OTC.

• Zydis® Bio Technology, Grazax® & Grastek®: Revolutionizing Allergy Therapy

  ALK-Abelló is a global research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. Before ALK-Abelló partnered with Catalent, all marketed allergen immunotherapies were delivered by injection, resulting in a limited patient population and reduced patient adherence. Catalent worked with the client to apply Zydis Fast Dissolve Technology to their therapy, bringing a vastly superior product to market.

• LV Scale-Up Workflow In Single-Use Bioreactors For GMP Compliance

  Cost-effective manufacturing of lentiviral vectors (LV) at commercial scales has proven difficult and remains a pressing issue for the marketing of therapies that depend on their application.

• Quality Matters – SEC Analysis For Antibody Aggregates

  Size exclusion chromatography (SEC) is the go-to analytical method in the analysis of therapeutic protein drugs. This article describes the factors affecting the reproducibility of columns and how you can minimize column variation.

• Kaleido Biosciences Successfully Meets Aggressive IND Filing Thanks To Strategic Partnership

  Designed specifically for new and emerging companies such as Kaleido Biosciences, The Quick to Care™ program is an integrated solution that combines drug substance and drug product development, clinical manufacturing, forecasting, demand planning and clinical trial supply execution managed by a single program manager.